Biomarkers in acute decompensated heart failure

Andrew N. Rosenbaum, Wayne L. Miller

Research output: Contribution to journalArticle

Abstract

Acute decompensated heart failure (ADHF) is a prominent condition whose frequency is increasing, especially in the context of an aging population. The ability to discern the cause of undifferentiated dyspnea in acute presentations is an increasing struggle. In this review, we seek to explore the various biomarkers that have been studied for the diagnosis of ADHF and their respective clinical utilities as the most recent data would suggest. Natriuretic peptides, galectin-3, soluble ST2, adrenomedullin, cardiac troponin-T, neutrophil gelatinase-associated lipocalin, and copeptin are reviewed. Of these biomarkers, natriuretic peptides are the most thoroughly evaluated and show the most promise for diagnosis or exclusion of acute heart failure, though other biomarkers can add significant utility in the form of prognostication.

Original languageEnglish (US)
Pages (from-to)33-42
Number of pages10
JournalClinical Medicine Insights: Therapeutics
Volume7
DOIs
StatePublished - Jul 16 2015

Fingerprint

Natriuretic Peptides
Heart Failure
Biomarkers
Adrenomedullin
Galectin 3
Troponin T
Dyspnea
Population
copeptins
Lipocalin-2

Keywords

  • Acute decompensated heart failure
  • Biomarkers
  • Diagnosis
  • NT-proBNP

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmaceutical Science
  • Pharmacology

Cite this

Biomarkers in acute decompensated heart failure. / Rosenbaum, Andrew N.; Miller, Wayne L.

In: Clinical Medicine Insights: Therapeutics, Vol. 7, 16.07.2015, p. 33-42.

Research output: Contribution to journalArticle

Rosenbaum, Andrew N. ; Miller, Wayne L. / Biomarkers in acute decompensated heart failure. In: Clinical Medicine Insights: Therapeutics. 2015 ; Vol. 7. pp. 33-42.
@article{5244bd172a9f447e9931aea220c25944,
title = "Biomarkers in acute decompensated heart failure",
abstract = "Acute decompensated heart failure (ADHF) is a prominent condition whose frequency is increasing, especially in the context of an aging population. The ability to discern the cause of undifferentiated dyspnea in acute presentations is an increasing struggle. In this review, we seek to explore the various biomarkers that have been studied for the diagnosis of ADHF and their respective clinical utilities as the most recent data would suggest. Natriuretic peptides, galectin-3, soluble ST2, adrenomedullin, cardiac troponin-T, neutrophil gelatinase-associated lipocalin, and copeptin are reviewed. Of these biomarkers, natriuretic peptides are the most thoroughly evaluated and show the most promise for diagnosis or exclusion of acute heart failure, though other biomarkers can add significant utility in the form of prognostication.",
keywords = "Acute decompensated heart failure, Biomarkers, Diagnosis, NT-proBNP",
author = "Rosenbaum, {Andrew N.} and Miller, {Wayne L.}",
year = "2015",
month = "7",
day = "16",
doi = "10.4137/CMT.S18476",
language = "English (US)",
volume = "7",
pages = "33--42",
journal = "Clinical Medicine Insights: Therapeutics",
issn = "1179-559X",
publisher = "Libertas Academica Ltd.",

}

TY - JOUR

T1 - Biomarkers in acute decompensated heart failure

AU - Rosenbaum, Andrew N.

AU - Miller, Wayne L.

PY - 2015/7/16

Y1 - 2015/7/16

N2 - Acute decompensated heart failure (ADHF) is a prominent condition whose frequency is increasing, especially in the context of an aging population. The ability to discern the cause of undifferentiated dyspnea in acute presentations is an increasing struggle. In this review, we seek to explore the various biomarkers that have been studied for the diagnosis of ADHF and their respective clinical utilities as the most recent data would suggest. Natriuretic peptides, galectin-3, soluble ST2, adrenomedullin, cardiac troponin-T, neutrophil gelatinase-associated lipocalin, and copeptin are reviewed. Of these biomarkers, natriuretic peptides are the most thoroughly evaluated and show the most promise for diagnosis or exclusion of acute heart failure, though other biomarkers can add significant utility in the form of prognostication.

AB - Acute decompensated heart failure (ADHF) is a prominent condition whose frequency is increasing, especially in the context of an aging population. The ability to discern the cause of undifferentiated dyspnea in acute presentations is an increasing struggle. In this review, we seek to explore the various biomarkers that have been studied for the diagnosis of ADHF and their respective clinical utilities as the most recent data would suggest. Natriuretic peptides, galectin-3, soluble ST2, adrenomedullin, cardiac troponin-T, neutrophil gelatinase-associated lipocalin, and copeptin are reviewed. Of these biomarkers, natriuretic peptides are the most thoroughly evaluated and show the most promise for diagnosis or exclusion of acute heart failure, though other biomarkers can add significant utility in the form of prognostication.

KW - Acute decompensated heart failure

KW - Biomarkers

KW - Diagnosis

KW - NT-proBNP

UR - http://www.scopus.com/inward/record.url?scp=84941640231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941640231&partnerID=8YFLogxK

U2 - 10.4137/CMT.S18476

DO - 10.4137/CMT.S18476

M3 - Article

AN - SCOPUS:84941640231

VL - 7

SP - 33

EP - 42

JO - Clinical Medicine Insights: Therapeutics

JF - Clinical Medicine Insights: Therapeutics

SN - 1179-559X

ER -